Core Viewpoint - Zhejiang Haisheng Medical Devices Co., Ltd. is conducting an online roadshow for its public stock issuance and listing on the Beijing Stock Exchange, highlighting significant advancements in the industrial application of its core technologies [1] Group 1: Company Innovations - The company has addressed various technical challenges associated with traditional medical products, such as operational inconvenience, subpar performance, and cross-infection risks through technological innovation [1] - Products developed by the company exhibit outstanding industry advantages in safety, miniaturization, data accuracy, and user experience [1] - The company's products are adaptable to a variety of complex clinical application scenarios, effectively meeting diverse needs across different medical departments [1] Group 2: Market Impact - The innovations are designed to enhance the efficiency of healthcare personnel and increase product usage stickiness among downstream customers [1]
海圣医疗：核心产品直击临床痛点，深度覆盖下游多样化需求
Sou Hu Cai Jing·2026-02-03 11:45